19 November 2019
Using CANTAB to characterize the development of cognition in a longitudinal neuroimaging cohort of healthy adolescents
Dr Qiang Luo, Associate Principal Investigator at the Institute of Science and Technology for Brain-inspired Intelligence - Fudan University, shared the role that CANTAB played in his latest publication: Adolescent binge drinking disrupts normal trajectories for brain functional organization and personality maturation.
5 November 2019
Clinical outcome assessments administered with pen-and-paper tasks have long been the assessment method of choice for measuring treatment effects on patients. However, with the advent of electronic alternatives - how do these two assessment methods compare?
11 October 2019
1 October 2019
Senior Psychology Technician at Teesside University, Nicole Beddard, shared her experience of administrating a CANTAB departmental licence.
17 September 2019
Are memory impairments in early and chronic schizophrenia related to the volume of particular hippocampal subfields?
Cassandra Wannan, final year PhD student at the University of Melbourne, shared the role that CANTAB played in her latest publication: Hippocampal subfields and visuospatial associative memory across stages of schizophrenia-spectrum disorder.
3 September 2019
What is the value of including cognitive assessments in the quantification of vascular and neuronal pathology in dementia using PET and MRI?
We caught up with researchers from the Division of Neuroscience and Experimental Psychology, University of Manchester to discuss the role that CANTAB plays in their cutting-edge neuroimaging study.
23 August 2019
Following steady improvements in survival rates, there is a growing interest in establishing the long-term side effects of cancer treatments. This includes a need for a better understanding of the cognitive safety profile of these interventions, particularly in children and adolescents. In this article, we demonstrate that CANTAB computerised assessments offer a sensitive and practical solution for assessing cognitive function in oncology trials.